← Back to Clinical Trials
Recruiting NCT07497464

NCT07497464 Validity of an Open-access Handedness Recognition Task in Stroke Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07497464
Status Recruiting
Phase
Sponsor Alfredo Lerín Calvo
Condition Stroke
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2025-10-07
Primary Completion 2026-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2025-10-07 with a primary completion date of 2026-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to assess the validity of a hand laterality discrimination task in patients who have suffered a stroke. The protocol involves two assessment sessions consisting of a Single Reaction Time (SRT) task and a Hand Laterality Judgement Task (HLJT). In the HLJT, participants are presented with images of right or left hands at various degrees of rotation and must determine the laterality of each hand. Primary outcomes include reaction time for the SRT, and both accuracy (percentage of correct responses) and decision-making time for the HLJT. Additionally, motor and kinesthetic imagery scales, as well as demographic and cognitive variables, are recorded.

Eligibility Criteria

Inclusion Criteria: * Adults (\>18 years old) with Stroke * MoCA score \> 21 points Exclusion Criteria: * Other neurological conditions * Severe cognitive impairment

Contact & Investigator

Central Contact

Marcos Moreno Verdú, Physical Therapist

✉ marcos.morenoverdu@uclouvain.be

📞 +34 630 01 29 25

Frequently Asked Questions

Who can join the NCT07497464 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07497464 currently recruiting?

Yes, NCT07497464 is actively recruiting participants. Contact the research team at marcos.morenoverdu@uclouvain.be for enrollment information.

Where is the NCT07497464 trial being conducted?

This trial is being conducted at Madrid, Spain.

Who is sponsoring the NCT07497464 clinical trial?

NCT07497464 is sponsored by Alfredo Lerín Calvo. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology